Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 2 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Palisade Bio, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 13 | 16 | +3 |
| Shares | 149.9K | 304.0K | +154.0K (+102.7%) |
| Value | $86.6K | $158.3K | +$71.7K (+82.8%) |
New holders (5)
Institutions that held Palisade Bio, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 54,800 | $32.0K | 0.00% |
| Virtu Financial LLC | 51,928 | $31.0K | 0.00% |
| Two Sigma Securities, LLC | 19,652 | $11.6K | 0.00% |
| FMR LLC | 38 | $22 | 0.00% |
| Marex Group plc | 35,759 | – | – |
Sold out (2)
Institutions that held Palisade Bio, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Baader Bank INC | 10,423 | $5.41K |
| Advisor Group Holdings, Inc. | 221 | $128 |